Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2007-2-7
pubmed:abstractText
Lack of leptin is implicated in insulin resistance and other metabolic abnormalities in generalized lipodystrophy; however, the efficacy, safety, and underlying mechanisms of leptin-replacement therapy in patients with generalized lipodystrophy remain unclear.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0021-972X
pubmed:author
pubmed:issnType
Print
pubmed:volume
92
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
532-41
pubmed:meshHeading
pubmed-meshheading:17118991-Adolescent, pubmed-meshheading:17118991-Adult, pubmed-meshheading:17118991-Albuminuria, pubmed-meshheading:17118991-Blood Glucose, pubmed-meshheading:17118991-Child, pubmed-meshheading:17118991-Diabetes Complications, pubmed-meshheading:17118991-Fatty Liver, pubmed-meshheading:17118991-Female, pubmed-meshheading:17118991-Follow-Up Studies, pubmed-meshheading:17118991-Glucose Clamp Technique, pubmed-meshheading:17118991-Glucose Tolerance Test, pubmed-meshheading:17118991-Hormone Replacement Therapy, pubmed-meshheading:17118991-Humans, pubmed-meshheading:17118991-Hyperinsulinism, pubmed-meshheading:17118991-Injections, Subcutaneous, pubmed-meshheading:17118991-Insulin Resistance, pubmed-meshheading:17118991-Leptin, pubmed-meshheading:17118991-Lipodystrophy, pubmed-meshheading:17118991-Male, pubmed-meshheading:17118991-Time Factors, pubmed-meshheading:17118991-Treatment Outcome, pubmed-meshheading:17118991-Triglycerides
pubmed:year
2007
pubmed:articleTitle
Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy.
pubmed:affiliation
Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, 54 Shogoin Kyoto 606-8507, Japan. Kebihara@kuhp.kyoto-u.ac.jp
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't